BIO-RAD LABORATORIES, INC. (BIO) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21
	8-K	10-Q	10-Q	10-Q	8-K	10-Q	10-Q	10-Q
Net sales	681.1	676.8	691.1	700.1	732.8	747.0	715.9	726.8
Net sales growth	-1.4%	-3.3%	-3.5%	-3.7%	-7.2%	15.4%	33.3%	27.2%
Cost of goods sold		314.4	295.1	297.4		309.6	314.3	326.2
Gross profit	362.5	362.4	396.0	402.6	401.0	437.4	401.6	400.6
Gross margin	53.2%	53.5%	57.3%	57.5%	54.7%	58.6%	56.1%	55.1%
Selling, general and administrative expense	207.8	225.6	208.7	196.7	224.1	216.2	213.4	225.9
Research and Development Expense	65.0	75.0	67.0	59.5	69.9	64.5	63.4	73.9
Segment profit (loss)	89.6	61.9	120.2	146.4	107.0	156.8	124.8	100.9
Operating margin	13.2%	9.1%	17.4%	20.9%	14.6%	21.0%	17.4%	13.9%
Interest expense	-12.3	-12.3	-10.7	-4.0	-0.4	-0.4	-0.4	-0.4
Foreign exchange (gains) losses, net	-1.3	-2.3	0.9	-2.1		2.2	-1.8	0.1
Marketable Securities, Unrealized (Gain) Loss		17.5	1,338.2	4,545.1		-4,868.7	-1,030.7	-1,179.4
Other Nonoperating Income (Expense)		50.4	6.7	32.6	10.0	-0.6	-0.1	17.4
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest		84.8	-1,222.9	-4,368.0		5,022.2	1,156.8	1,297.2
(Provision) benefit for income taxes	338.2	-15.9	295.7	1,000.7	464.4	-1,094.2	-242.7	-319.8
Net income attributable to Bio-Rad	-1,162.3	69.0	-927.2	-3,367.3	-1,573.7	3,928.0	914.1	977.4

Basic earnings per share:
Net income per share basic attributable to Bio-Rad	($39.59)	$2.33	($31.12)	($112.50)	($52.59)	$131.75	$30.71	$32.77

Weighted average common shares - basic	29.4	29.6	29.8	29.9	29.9	29.8	29.8	29.8

Diluted earnings per share:
Net income per share diluted attributable to Bio-Rad	($39.59)	$2.32	($31.12)	($112.50)	($52.59)	$129.96	$30.32	$32.38
Weighted average common shares - diluted	29.4	29.7	29.8	29.9	29.9	30.2	30.1	30.2